Go to article
Posted by CoV Report on May 18, 2021 1:15 amTags: Categories: Global Stories
Medicago said a Phase 2 clinical trial involving hundreds of participants found the vaccine appears to produce 10 times the antibodies as are seen in people who have had COVID-19.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply